Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2330 Inwood Rd Biocenter
Dallas, TX 75390Phone+1 214-648-4791Fax+1 916-734-2560
Summary
- Dr. Mingyi Chen is a pathologist in Irving, TX and is affiliated with University of Texas Southwestern Medical Center. He received his medical degree from Beijing Medical University and has been in practice 20 years. He specializes in hematopathology, anatomic pathology, and clinical pathology.
Education & Training
- City of Hope National Medical CenterFellowship, Hematopathology, 2009 - 2010
- Beijing Medical UniversityClass of 1992
Certifications & Licensure
- TX State Medical License 2017 - 2026
- CA State Medical License 2007 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Ferredoxin 2 Is Critical for Tumor Suppression and Lipid Homeostasis but Dispensable for Embryonic Development.Jin Zhang, Yanhong Zhang, Shakur Mohibi, Vivian Perng, Miranda Bustamante
The American Journal of Pathology. 2025-04-01 - Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment.Ruifang Zheng, Jeffrey R Gagan, Giovanni A Botten, Prasad Koduru, Olga K Weinberg
European Journal of Haematology. 2025-03-18 - 2 citationsGenomic and Clinicopathological Characterization of CRLF2-Rearranged Mixed Phenotype Acute Leukemia.Lina Han, Ruifang Zheng, Franklin Fuda, Miguel D Cantu, Prasad Koduru
Pediatric Blood & Cancer. 2025-03-01
Committees
- member, Texas Society of Pathology Educational Committee 2021 - 2024
Research History
- ProfessorRESEARCH INTERESTS • Biomarker development of cancer diagnosis, cancer stem cells, immunotherapy. • Molecular pathogenesis of lymphoma and leukemia, tumor immunology and GVHD • Atherosclerosis, thrombosis, vascular biology, sickle cell disease and lipid metabolism2009 - 2030
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: